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Summary  A  50-year-old  man  in  chemotherapy  for  an  advanced  lung  adenocarcinoma  pre-
sented  with  chest  pain  and  cutaneous  rash  during  carboplatin  infusion  with  electrocardiographic
(ECG) evidence  of  an  inferior  lesion  wave.  The  administration  of  steroids  and  nitrates  promptlyVasospasm resulted  in  clinical  and  ECG  normalization,  without  enzymatic  dismission.  This  reaction  was
considered  compatible  with  allergic  coronary  vasospasm  (also  known  as  Kounis  syndrome),  a
rare  but  possible  complication  of  chemotherapy.  In  these  cases  prompt  diagnosis  and  a  correct
approach  can  avoid  useless  invasive  interventions.
©  2011  Japanese  College  of  Cardiology.  Published  by  Elsevier  Ltd.  All  rights  reserved.
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ardiac  damage  cause  caused  by  chemotherapy  is  a  com-
lex topic  and  its  pathogenesis  is  still  unclear.  Here  we
eport a  case  of  coronary  vasospasm  caused  by  carboplatin
ypersensitivity, a  phenomenon  never  reported  before  in  the
iterature.
ase report
 50-year-old  man  was  admitted  to  the  oncology  depart-
ent for  the  6th  cycle  of  chemotherapy  for  an  inferior  leftung adenocarcinoma,  diagnosed  four  years  previously.  A
ew weeks  after  diagnosis  he  was  subjected  to  pulmonary
obectomy, without  evidence  of  lymphonodal  involvement.
∗ Corresponding author. Tel.: +39 3288873696;
ax: +39 0350661200.
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oi:10.1016/j.jccase.2011.04.004n  the  third  year  of  follow-up  a  technetium  positron  emis-
ion tomography  examination  showed  hypercaptation  in  left
ylar and  subclavear  lymph  nodes  with  an  increase  in  plas-
atic carcinoembryonic  antigen  (CEA),  and  chemotherapy
ith carboplatin  plus  paclitaxel  was  initiated.  The  patient’s
amily and  clinical  history  were  negative  for  cardiovascu-
ar disease,  but  he  had  smoked  about  10  cigarettes  per
ay for  30  years.  His  pharmacological  history  included  a
roton pump  inhibitor  (omeprazole).  He  stayed  in  hospital
or two  days  on  each  of  the  ﬁrst  ﬁve  cycles  with  a  free
nterval of  two  weeks  between  doses.  The  basal  electro-
ardiogram (ECG)  at  every  admission  was  normal.  During
he 6th  infusion  of  450  mg  of  carboplatin  in  dextrose  5%  he
uffered intense  chest  pain  and  a  diffuse  cutaneous  rash.
n ECG  performed  during  the  pain  (Fig.  1)  showed  a  2.5-
m ST  segment  elevation  in  inferior  leads  (II,  III,  aVF)  with
eciprocal ST  depression  in  V1—V3.  Before  the  arrival  of  the
ardiologist a  sublingual  nitroglycerin  tablet  and  40  mg  of
etylprednisolone IV  were  administered,  with  prompt  relief
f symptoms  and  fast  regression  of  the  cuteneous  rash.  A
econd ECG  (Fig.  2)  performed  30  min  later  showed  inver-
 Published by Elsevier Ltd. All rights reserved.
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Figure  1  Electrocardiogram  during  pain.
Figure  2  Electrocardiogram  after  pain  cessation.
e60  M.  Baroni  et  al.
ardio
s
a
T
a
m
f
r
p
n
c
n
w
l
d
(
r
a
6
2
a
i
c
r
c
D
C
f
p
h
a
H
w
a
e
5
t
c
u
b
i
i
a
ﬁ
e
o
o
t
‘
a
i
s
b
i
d
aFigure  3  Electroc
ion  of  T  waves  in  inferior  leads  with  the  onset  of  fast
trial ﬁbrillation  (140  bpm).  Plasmatic  values  of  troponin
, creatine  kinase-MB,  and  myoglobin  were  not  signiﬁcant
t 0,  6,  and  12  h  after  the  event.  Arterial  blood  pressure
aintained values  above  100/60  mmHg.  The  patient  refused
urther invasive  procedures  (e.g.  coronary  angiography)  and
equested hospital  discharge  the  day  after  the  event.  Com-
lete blood  count  showed  only  mild  eosinophilia  (5%)  and
eutrophilia (75%)  with  no  abnormalities  of  other  blood
ells. Hepatic,  electrolyte,  creatine  kinase,  blood  urea
itrogen, and  creatine  ﬁndings  were  normal.  Total  serum  IgE
as  elevated  (306  kU/L),  but  serum  histamine  and  tryptase
evels were  not  performed.  Skin  tests  were  not  performed,
ue to  the  patient’s  refusal.  An  ECG  before  discharge
Fig. 3)  showed  normalization  of  T  waves  and  spontaneous
estoration of  sinus  rhythm.  The  patient  was  dismissed  with
spirin therapy  and  did  not  refer  to  chest  pain  during  a
-month follow-up  period.  An  ambulatory  ECG  stress  test
 months  after  the  event  was  negative  for  ischemic  ST-T
lterations and  an  echocardiogram  showed  no  alterations
n systolic  and  diastolic  function  compared  to  a  pre-event
ontrol. On  that  occasion,  the  repeated  serum  IgE  level  had
eturned to  normal  (80  kU/L)  with  no  alterations  in  the  blood
ount.
iscussionardiac  damage  caused  by  antineoplastic  agents  has  been
requently reported  in  the  literature.  Most  chemothera-
eutic drugs  seem  to  be  directly  cardiotoxic  and  their
armful effects  can  cause  several  heart  problems  such  as
m
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tgram  at  discharge.
rrhythmias,  left  ventricular  dysfunction,  and  ischemia.
owever, not  all  chemotherapeutics  are  directly  correlated
ith cardiotoxicity  and  only  a  few  of  them  have  been
ssociated with  cardiac  ischemia.  There  is  strong  clinical
vidence [1]  that  some  antimetabolic  agents  (capecitabine,
-FU), antimicrotubular  agents  (paclitaxel,  docetaxel),  and
yrosine kinase  inhibitors  (sorafenib,  bevaciuzmab)  can
ause cardiac  ischemia,  but  their  pathogenic  mechanism  is
nknown. On  the  other  hand,  platinum  compounds  seem  to
e less  cardiotoxic,  but  they  are  more  frequently  involved
n hypersensitivity  reactions  [2].
Kounis  syndrome,  or  allergic  angina,  was  ﬁrst  described
n 1991  as  the  coincidental  occurrence  of  chest  pain  and
llergic reaction  accompanied  by  clinical  and  instrumental
ndings of  classic  angina  pectoris  [3].  At  a later  date,  Kounis
t al.  [4]  proposed  a  differentiation  between  two  variants
f the  syndrome:  the  ‘‘Type  I’’  in  which  coronary  spasm
ccurs in  normal  vessels  and  may  represent  a  manifesta-
ion of  microvascular  angina  (such  as  X  syndrome),  and  the
‘Type II’’  in  which  the  allergic  reaction  seems  to  damage
 previously  quiescent  atherosclerotic  plaque,  resulting  in
ts rupture  with  the  consequent  ‘‘classic’’  acute  coronary
yndrome.
The pathogenesis  of  this  phenomenon  may  be  explained
y an  abnormal  reaction  of  coronary  smooth  muscle  to  many
nﬂammatory mediators.  In  particular,  rapid  mast  cells’
egranulation (mainly  IgE-mediated)  that  occurs  during  an
naphylactic reaction  can  cause  the  release  of  many  inﬂam-
atory mediators  such  as  histamine,  neutral  proteases,
latelet activating  factor,  and  arachidonic  acid  derivatives.
ll these  compounds  can  induce  coronary  spasm,  even  in
he absence  of  atherosclerotic  plaques.  Moreover,  histamine
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can  activate  platelets  and  stimulate  tissue  factor  expression
causing a  prothrombotic  state  [5].
In  recent  years,  several  cases  of  Kounis  syndrome  have
been documented  in  the  literature  with  a  various  range
of allergic  triggers,  such  as  drugs,  foods,  and  even  insect
bites. This  phenomenon  is  probably  underdiagnosed  because
often chest  pain  is  not  the  main  symptom  referred  to  by  the
patient and  consequently  an  ECG  is  not  performed.
At  present,  only  two  cases  of  acute  coronary  syn-
drome with  ST  elevation  induced  by  carboplatin  have  been
reported, one  with  chest  pain  as  the  only  clinical  presenta-
tion [6]  and  the  other  with  acute  shock  [7].  Both  resolved
in a  short  period  and  both  cases  with  normal  coronaries  at
angiography were  presentations  compatible  with  coronary
vasospasm.
Neither of  these  cases  presented  with  signs  of  an  allergic
reaction, as  found  in  this  patient  (who  had  a  massive  cuta-
neous rash  and  ST  elevation).  Even  if  the  patient  declined
angiographic examination,  negative  cycloergometric  ECG
stress  test  and  echocardiogram  were  considered  sufﬁcient
for the  exclusion  of  major  coronary  artery  stenosis.  Con-
sidering all  these  elements,  this  case  can  be  interpreted
as the  ﬁrst  one  described  in  the  literature  of  a  complete
manifestation of  Kounis  syndrome  type  I.
This  report  also  suggests  that  a  rapid  search  for  hypersen-
sitivity signs  or  symptoms  (such  as  cutaneous  rash,  urticaria,
asthma, etc.)  should  be  done  in  patients  with  a  new  onset
[e61
f  angina  and  ST-elevation  during  chemotherapy  and,  most
f  all,  an  ECG  should  always  be  performed  in  patients  with
n important  allergic  reaction.
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